Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial).
Konstantinos PapamichaelVipul JairathGuangyong ZouBenjamin CohenTimothy RitterBruce SandsCorey SiegelJohn ValentineMichelle SmithNiels Vande CasteeleMarla DubinskyAdam CheifetzPublished in: BMJ open (2022)
NCT04835506.